Use of cardioactive drugs in acute myocardial infarction.
D000137:Acid-Base Imbalance; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001806:Blood Urea Nitrogen; D002118:Calcium / Q000378:metabolism; D006321:Heart / Q000503:physiopathology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008564:Membrane Potentials; D009124:Muscle Proteins / Q000378:metabolism; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009399:Nephrons / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D012964:Sodium / Q000378:metabolism; D014883:Water-Electrolyte Imbalance
D000889:Anti-Arrhythmia Agents; D009124:Muscle Proteins; D008012:Lidocaine; D012964:Sodium; D011802:Quinidine; D011342:Procainamide; D011188:Potassium; D002118:Calcium